FAS and prostate carcinoma: In LNCaP human prostate carcinoma cells, USP2a knockdown using targeted siRNA increases levels of poly-ubiquitinated FAS, reduces levels of FAS protein, and promotes induction of apoptosis (5, 7, 9).